NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study
Vahid Asnafi(Hôpital Necker-Enfants Malades), Elizabeth Macintyre(Inserm), Françoise Huguet(Centre Hospitalier Universitaire de Toulouse), Agnès Buzyn(Hôpital Saint-Jacques), Emmanuelle Tavernier(Institute Cancer De La Loire Lucien Neuwirth), Arnauld Simon(Hôpital Necker-Enfants Malades), Sandrine Le Noir(Hôpital Necker-Enfants Malades), Pascal Turlure(Centre Hospitalier Universitaire de Limoges), Francis Witz(Centre Hospitalier Régional et Universitaire de Nancy), Norbert Ifrah(Institut National du Cancer), Thibaut Leguay(Centre Hospitalier Universitaire de Bordeaux), Thierry Fagot(Hôpital d'instruction des Armées Percy), Frédéric Baleydier(University of Geneva), Marie C. Béné(Centre Hospitalier Universitaire de Nantes), Xavier Thomas(Hôpital Lyon Sud), Kheïra Beldjord(Inserm), Francis Daniel(Plymouth Hospital), Oumédaly Reman(Centre Hospitalier Universitaire de Caen), Jean‐Paul Vernant(Hôpital Saint-Jacques), Hervé Dombret(University of London Institute in Paris)
Cited by 242
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k